Patents by Inventor Mark Anthony Morris

Mark Anthony Morris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biaryl ether urea compounds
    Patent number: 8044052
    Abstract: The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.
    Type: Grant
    Filed: October 18, 2007
    Date of Patent: October 25, 2011
    Assignee: Pfizer Inc.
    Inventors: Lorraine Kathleen Fay, Douglas S. Johnson, Suzanne Ross Kesten, Scott E. Lazerwith, Mark Anthony Morris, Cory Michael Stiff, Marvin Jay Meyers, Lijuan Jane Wang
  • HETERO BIARYL DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS
    Publication number: 20090029995
    Abstract: This invention provides compounds defined by Formula I or a pharmaceutically acceptable salt thereof, wherein R1, Q, S, T, U, V, and R2 are as defined in the specification. The invention also provides pharmaceutical compositions and methods of treating diseases.
    Type: Application
    Filed: November 29, 2006
    Publication date: January 29, 2009
    Applicants: WARNER-LAMBERT COMPANY, WARNER-LAMBERT COMPANY LLC
    Inventors: Amy Mae Bunker, Mark Anthony Morris, Patrick Michael O'Brien, Michael William Wilson
  • Biaryl Ether Urea Compounds
    Publication number: 20080261941
    Abstract: The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.
    Type: Application
    Filed: October 18, 2007
    Publication date: October 23, 2008
    Inventors: Lorraine Kathleen FAY, Douglas S. Johnson, Suzanne Ross Kesten, Scott E. Lazerwith, Mark Anthony Morris, Cory Michael Stiff, Marvin Jay Meyers, Lijuan Jane Wang
  • Hetero biaryl derivatives as matrix metalloproteinase inhibitors
    Patent number: 7179822
    Abstract: This invention provides compounds defined by Formula I and pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier, diluent, or excipient. The invention also provides methods of treating osteo- and rheumatoid arthritis.
    Type: Grant
    Filed: August 5, 2003
    Date of Patent: February 20, 2007
    Assignees: Warner-Lambert Company, Warner-Lambert Company LLC
    Inventors: Amy Mae Bunker, Mark Anthony Morris, Patrick Michael O'Brien, Michael William Wilson
  • Hetero biaryl derivatives as matrix metalloproteinase inhibitors
    Publication number: 20040048863
    Abstract: This invention provides compounds defined by Formula I 1
    Type: Application
    Filed: August 5, 2003
    Publication date: March 11, 2004
    Inventors: Amy Mae Bunker, Mark Anthony Morris, Patrick Michael O'Brien, Michael William Wilson